NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $140,000 | +125.8% | 53,730 | +43.5% | 0.00% | – |
| Q4 2018 | $62,000 | -47.9% | 37,442 | +52.4% | 0.00% | – |
| Q3 2018 | $119,000 | -27.0% | 24,571 | -5.8% | 0.00% | – |
| Q2 2018 | $163,000 | -5.8% | 26,071 | +25.1% | 0.00% | – |
| Q1 2018 | $173,000 | -6.5% | 20,845 | +14.8% | 0.00% | – |
| Q4 2017 | $185,000 | -3.1% | 18,160 | -13.1% | 0.00% | – |
| Q3 2017 | $191,000 | +28.2% | 20,909 | +2.4% | 0.00% | – |
| Q2 2017 | $149,000 | +15.5% | 20,409 | +13.6% | 0.00% | – |
| Q1 2017 | $129,000 | +69.7% | 17,968 | +38.4% | 0.00% | – |
| Q4 2016 | $76,000 | +15.2% | 12,983 | +28.5% | 0.00% | – |
| Q3 2016 | $66,000 | – | 10,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|